Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Quinolinic acid is an active metabolite of tryptophan (Item Nos. 29600 | 31210) and an NMDA receptor agonist.1,2 It is formed from tryptophan via the kynurenine pathway.1 Quinolinic acid (100 µM) induces lipid peroxidation in rat brain synaptosomes, an effect that can be reversed by the NMDA receptor antagonist 2-amino-5-phosphonovaleric acid.3 It decreases the viability of primary rat neurons when used at a concentration of 25 µM.4 Intracerebroventricular administration of quinolinic acid (1 µg/animal) induces convulsions in mice.5 Increased plasma levels of quinolinic acid negatively correlate with Brief Neurocognitive Assessment (BNA) scores in patients with schizophrenia.6
WARNING This product is not for human or veterinary use.
1. Human microglia convert L-
2. Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 72(4), 411-412 (1981).
3. Kynurenine 3-
4. Melanocortin receptor agonist ACTH 1-
5. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J. Neural. Transm. 42(1), 37-43 (1978).
6. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder. Sci. Rep. 11(1), 9992 (2021).